Xspray Pharma AB (publ) (XSPRAY.ST)
XSPRAY.ST Stock Price Chart
Explore Xspray Pharma AB (publ) interactive price chart. Choose custom timeframes to analyze XSPRAY.ST price movements and trends.
XSPRAY.ST Company Profile
Discover essential business fundamentals and corporate details for Xspray Pharma AB (publ) (XSPRAY.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 Sept 2017
Employees
27.00
Website
https://www.xspraypharma.comCEO
Per Andersson
Description
Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo for the treatment of chronic myeloid leukemia; HyNap-Sora for the treatment of renal cancer and liver cancer, as well as several forms of thyroid cancer; and HyNap-Dasa for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is based in Solna, Sweden.
XSPRAY.ST Financial Timeline
Browse a chronological timeline of Xspray Pharma AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 7 May 2025
EPS came in at -kr 1.14 surpassing the estimated -kr 1.81 by +37.02%.
Earnings released on 12 Feb 2025
EPS came in at -kr 2.36 falling short of the estimated -kr 1.82 by -29.67%.
Stock split effective on 12 Nov 2024
Shares were split 1011 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 6 Nov 2024
EPS came in at -kr 2.44 falling short of the estimated -kr 1.39 by -75.54%.
Earnings released on 7 Aug 2024
EPS came in at -kr 1.64 falling short of the estimated -kr 1.55 by -5.81%, while revenue for the quarter reached kr 930.00K .
Earnings released on 8 May 2024
EPS came in at -kr 2.17 , while revenue for the quarter reached kr 134.00K .
Earnings released on 14 Feb 2024
EPS came in at -kr 1.85 .
Earnings released on 8 Nov 2023
EPS came in at -kr 1.59 , while revenue for the quarter reached kr 29.20M .
Earnings released on 2 Aug 2023
EPS came in at -kr 2.27 .
Earnings released on 4 May 2023
EPS came in at -kr 1.50 .
Earnings released on 15 Feb 2023
EPS came in at -kr 2.48 falling short of the estimated -kr 2.14 by -15.89%.
Earnings released on 9 Nov 2022
EPS came in at -kr 1.39 surpassing the estimated -kr 2.53 by +45.06%.
Earnings released on 5 Aug 2022
EPS came in at -kr 1.40 falling short of the estimated -kr 0.93 by -50.54%.
Earnings released on 6 May 2022
EPS came in at -kr 0.92 surpassing the estimated -kr 2.53 by +63.64%.
Earnings released on 18 Feb 2022
EPS came in at -kr 2.62 falling short of the estimated -kr 1.48 by -77.03%.
Earnings released on 26 Oct 2021
EPS came in at -kr 0.73 .
Earnings released on 6 Aug 2021
EPS came in at -kr 0.89 .
Earnings released on 6 May 2021
EPS came in at -kr 0.73 .
Earnings released on 25 Feb 2021
EPS came in at -kr 0.89 .
Earnings released on 20 Nov 2020
EPS came in at -kr 0.66 .
XSPRAY.ST Stock Performance
Access detailed XSPRAY.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.